Latest from @CombatCancer on Twitter

Just in case you missed this trial data presented at AUA20, #HIVEC immediately prior to TURBT shows equivalent recurrence to I-POP but with 100% adherence for HIVEC, 33% greater than for I-POP.https://bit.ly/3fjnHyD

https://laparoscopic-hipec-a-new-point-of-view.eventbrite.co.uk
@CombatCancer #HIPEC Don't forget to register to join Combat and Dr Alvaro-Arjona-Sanchez later today to find out more.

#HIPEC #Laparoscopic #SurgicalOncology @CombatCancer Join Combat and Consultant Surgeon Dr Alvaro-Arjona-Sanchez to find out more about Laparoscopic HIPEC experience and results. Register for online event https://laparoscopic-hipec-a-new-point-of-view.eventbrite.co.uk

Join @CombatCancer #HIVEC and Dr Alejandro Sousa for live clinical discussion and Q&A on HIVEC-R.
To register click https://combat-hivec.eventbrite.co.uk

@CombatCancer #HIVEC Neo-Adjuvant HIVEC shows over 60% complete response and better RFS in preliminary trial result. Abstract accepted for AUA20, follow link to see full abstract https://bit.ly/2W2bA1Q

Its #BladderCancerAwarenessMonth If you have any of the symptoms, blood in your urine, frequency or difficulty and pain during urination please pleas ego see your GP. It could save your life. Check out @CombatCancer for further details

El @DrFelixGuerrero presenta los resultados del ensayo HIVEC-HR, comunicado recientemente en #AUA20 @AmerUrological, en el webinar organizado por @CombatCancer #HIVEC #bladdercancer

➡ Más información: https://bit.ly/2A0qGwe
¡Sigue el webinar online 👉 https://bit.ly/3cV7HBV!

Load More...